Boucenna, A., Hirech, A., Larbi, R. M., & Satta, D. (2024). Impact of CYP2D6 Polymorphisms in Predicting Occurrence of Adverse Effect to Tamoxifen and Developing Recurrence in ER+ Breast Cancer Patients. Archives of Breast Cancer, 11(4). https://doi.org/10.32768/abc.2024114392-399